NASDAQ: ARTL
Artelo Biosciences Inc Stock Ownership - Who owns Artelo Biosciences?

Insider buying vs selling

Have Artelo Biosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARTL insiders and whales buy or sell their stock.

ARTL Shareholders

What type of owners hold Artelo Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter Michael Obrien48.71%345,000$1.30MInsider
Gregory D. Gorgas38.56%273,076$1.03MInsider
John Joseph Crawford13.51%95,671$359.72kInsider
Sharon M. Oster8.81%62,373$234.52kInsider
Connie Matsui8.00%56,667$213.07kInsider
Ubs Group Ag4.75%33,621$126.41kInstitution
Two Sigma Investments LP2.92%20,669$77.72kInstitution
Virtu Financial LLC2.38%16,865$63.41kInstitution
Vanguard Group Inc1.98%14,028$52.75kInstitution
Geode Capital Management LLC1.61%11,398$42.86kInstitution

1 of 3

ARTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTL10.57%89.43%
BRTX0.32%99.68%Net Buying
AZTR1.39%98.08%
SXTP1.48%98.52%Net Buying
ADIL43.37%56.63%

Artelo Biosciences Stock Ownership FAQ

Who owns Artelo Biosciences?

Artelo Biosciences (NASDAQ: ARTL) is owned by 13.91% institutional shareholders, 117.73% Artelo Biosciences insiders, and 0.00% retail investors. Peter Michael Obrien is the largest individual Artelo Biosciences shareholder, owning 345,000.00 shares representing 48.71% of the company. Peter Michael Obrien's Artelo Biosciences shares are currently valued at $1.30M.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.